OTC drug and dietary supplement industries still emphasize lobbying for allowing direct purchases of their [products with pre-tax health savings accounts; streamlining FDA's process for adding OTC monograph ingredients and indications; and making multivitamins eligible for purchase with food stamps. They also remain vigilant about keeping Congress' hands off DSHEA, which reaches its 25th anniversary in October.

With a new US Congress just convening, OTC monograph reform advocates face an old problem: the need for Senate action. The House has already cleared an OTC reform measure, as part of a pandemic preparedness bill, in the first days of the legislative session.

With Democrats in control of the House and New Jersey Rep. Frank Pallone in line for chair of the Energy & Commerce Committee, cosmetics regulatory reform legislation could receive even more attention in the 116^th Congress than in the current session. The new climate could test how serious big business is about embracing large-scale changes as well as lawmakers’ openness to federal preemption.